The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) have risen just 0.1% today as investors process the strong gains recorded across the board last week.
Although the market itself has remained mostly flat; there are a number of companies generating strong gains for their lucky shareholders today, including these four that you've probably never even heard of.
Martin Aircraft Company Ltd (ASX: MJP) surged 8.9% to 73.5 cents after climbing as much as 21.5% earlier in the session. The company, which is aiming to commercialise the Martin Jetpack as early as next year, said it had signed a Memorandum of Understanding with US-based AvWatch, Inc. to demonstrate airborne technology capabilities for the Department of Homeland Security and various other agencies.
The company's Chief Executive Officer, Peter Coker, acknowledged that the North American market presents excellent opportunities for Martin Aircraft in the future.
Orthocell Ltd (ASX: OCC) surged another 8% to trade at 60.5 cents, complementing Thursday's impressive 24.7% gain. The biomedical group provides innovative approaches to the regeneration of tendon, cartilage and soft tissue injuries. Last week, it referred to a publication that appeared in a medical journal which provided peer support for a similar approach to regeneration of damaged cartilage as is currently offered by Orthocell.
Hansen Technologies Limited (ASX: HSN) gained 5.2% to trade at $3.04 after hitting a fresh all-time high of $3.08 earlier in the session, despite the absence of any specific news that would explain the jump. Hansen provides billing solutions for service providers within the energy, Pay TV and telecommunications sectors with its shares up a remarkable 130% over the last 12 months.
Pro Medicus Limited (ASX: PME) gained 4.7% with its shares also hitting a new record high today at $2.52. Pro Medicus is a leading provider of radiology information systems, while it also provides integrated software applications, IT solutions and other services to the private healthcare industry. With a market capitalisation of $235 million, this could be one for long-term investors to keep a close eye on.
